Systematic Financial Management’s Integra LifeSciences IART Stock Holding History

Systematic Financial Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.4M	Sell	1,023,243 -36,043	-3%	-$504K	0.37%	103
2026 Q1	$9.98M	Sell	1,059,286 -49,313	-4%	-$541K	0.23%	136
2025 Q4	$13.8M	Buy	1,108,599 +48,094	+5%	+$639K	0.32%	121
2025 Q3	$15.2M	Buy	1,060,505 +3,585	+0.3%	+$49.1K	0.37%	107
2025 Q2	$13M	Buy	1,056,920 +120,086	+13%	+$1.74M	0.35%	111
2025 Q1	$20.6M	Buy	936,834 +76,271	+9%	+$1.79M	0.59%	69
2024 Q4	$19.5M	Buy	860,563 +248,817	+41%	+$5.43M	0.5%	89
2024 Q3	$11.1M	Buy	611,746 +214,272	+54%	+$4.97M	0.28%	129
2024 Q2	$11.6M	Buy	397,474 +335,424	+541%	+$9.95M	0.35%	116
2024 Q1	$2.2M	Buy	+62,050	New	+$2.48M	0.06%	179
2020 Q3	–	Sell	-7,075	Closed	-$332K	–	342
2020 Q2	$332K	Buy	+7,075	New	+$348K	0.02%	258

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Systematic Financial Management's IART Position: Q2 2026 in Review

Systematic Financial Management reduced its Integra LifeSciences (IART) stake by 3.4% in Q2 2026, selling an estimated $504K and leaving 1,023,243 shares worth $18.4M. The position accounts for 0.37% of the portfolio, ranked #103.

Systematic Financial Management first reported a position in IART in Q2 2020 and has held it in 11 quarters since. The position peaked at $20.6M in Q1 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Systematic Financial Management held 1,023,243 shares of Integra LifeSciences worth $18.4M as of Q2 2026.
Systematic Financial Management sold 36,043 Integra LifeSciences shares in Q2 2026, an estimated $504K.
Integra LifeSciences made up 0.37% of Systematic Financial Management's portfolio in Q2 2026, its #103 holding.
Systematic Financial Management first reported a position in Integra LifeSciences in Q2 2020 and has held it in 11 quarters since.
Systematic Financial Management's Integra LifeSciences position peaked at $20.6M in Q1 2025.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.